Quarterly turnover from beta agonists in Denmark 2018
This statistic shows the quarterly turnover from beta agonists for systematic use, to treat respiratory and pulmonary disease, in Denmark in 2018. The highest turnover during 2018 was in the first quarter, which amounted to 231.1 million Danish kroner.